Skip to main content
Log in

Continuous Positive Airway Pressure and Cardiovascular Events in Patients with Obstructive Sleep Apnea

  • Ischemic Heart Disease (D Mukherjee, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The obstructive sleep apnea syndrome (OSAS) is associated with the development/worsening of cardiovascular disease. OSAS is considered to be an independent risk factor for hypertension and is linked to increased mortality in the context of coronary heart disease, the development of cardiac arrhythmias and increased risk of developing mild pulmonary hypertension. OSAS is also associated with cerebrovascular mortality and morbidity. In heart failure, OSAS can lead to worsening of symptoms. Treatment of OSAS using positive airways pressure therapy (PAP) has been shown in randomized, controlled trials in selected populations to reduce some, but not all of these cardiovascular and cerebrovascular risks. Unequivocal evidence of causality for OSAS in the development, progression, and outcomes of these disorders in all individuals suffering from them, is lacking. Good quality long-term morbidity and mortality data for the effects of OSAS on cardiometabolic health and the impact of PAP treatment are likewise limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.

    PubMed  Google Scholar 

  2. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnea in adults. Cochrane Database Syst Rev. 2006;3, CD001106.

    PubMed  Google Scholar 

  3. Jennum P, Riha RL. Epidemiology of sleep apnea/hypoapnea syndrome and sleep-disordered breathing. Eur Respir J. 2009;33:907–14.

    Article  PubMed  CAS  Google Scholar 

  4. Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest. 2003;124:1400–5.

    Article  PubMed  Google Scholar 

  5. Hu FB, Willett WC, Manson JE, Colditz GA, Rimm EB, Speizer FE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol. 2000;35:308–13.

    Article  PubMed  CAS  Google Scholar 

  6. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000;283:1829–36.

    Article  PubMed  CAS  Google Scholar 

  7. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.

    Article  PubMed  CAS  Google Scholar 

  8. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.

    Article  PubMed  CAS  Google Scholar 

  9. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41.

    Article  PubMed  Google Scholar 

  10. McNicholas WT, Bonsigore MR. Sleep apnea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms, and research priorities. Management Committee of EU COST ACTION B26. Eur Respir J. 2007;29:156–78.

    Article  PubMed  CAS  Google Scholar 

  11. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–7.

    Article  PubMed  Google Scholar 

  12. Bradley TD, Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009;373:82–93.

    Article  PubMed  Google Scholar 

  13. Ferrier K, Campbell A, Yee B, Richards M, O'Meeghan T, Weatherall M, et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005;128:2116–22.

    Article  PubMed  Google Scholar 

  14. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625–31.

    Article  PubMed  Google Scholar 

  15. Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med. 1998;19:99–113.

    Article  PubMed  CAS  Google Scholar 

  16. Koehnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax. 2002;57:547–54.

    Article  Google Scholar 

  17. Riha RL. Clinical assessment of the obstructive sleep apnea/hypoapnea syndrome. Ther Adv Respir Dis. 2010;4:83–91.

    Article  PubMed  Google Scholar 

  18. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001;164:2147–65.

    Article  PubMed  CAS  Google Scholar 

  19. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180:692–700.

    Article  PubMed  CAS  Google Scholar 

  20. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598–605.

    Article  PubMed  Google Scholar 

  21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.

    Article  PubMed  CAS  Google Scholar 

  22. O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159–64.

    Google Scholar 

  23. Jones A, Vennelle M, Connell M, McKillop G, Newby DE, Douglas NJ, et al. Arterial stiffness and endothelial function in obstructive sleep, Apnea/Hypopnea Syndrome. Sleep Med. (in press).

  24. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417–23.

    Article  PubMed  CAS  Google Scholar 

  25. •• Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. European Respiratory Society; EU COST ACTION B26 members. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society, and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–46. Most complete and up-to-date consensus guidelines for assessing hypertension in the context of obstructive sleep apnea and vice versa.

  26. Butt M, Dwivedi G, Shantsila A, Khair OA, Lip GY. Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Circulation: Heart Failure. 2012;5:226–33.

    Google Scholar 

  27. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757–64.

    Article  PubMed  Google Scholar 

  28. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, Almeida-Gonzalez C. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006;129:1459–67.

    Google Scholar 

  29. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229–35.

    Google Scholar 

  30. Barbé F, Mayoralas LR, Duran J, Masa JF, Maimó A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134:1015–23.

    Google Scholar 

  31. •• Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in non-sleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161–8. Well-performed trial looking at hypertension and OSA in a large, multi-centers Spanish population.

  32. Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106–13.

    Google Scholar 

  33. Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009;51:363.

    Article  PubMed  Google Scholar 

  34. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52:343–6.

    Article  PubMed  Google Scholar 

  35. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;3:19–25.

    Article  Google Scholar 

  36. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Javier Nieto F, et al. Sleep disordered breathing and mortality: 18-year follow-up of the Wisconsin Sleep Cohort. Sleep. 2008;31:1071–8.

    PubMed  Google Scholar 

  37. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. 2006;28:596.

    Article  PubMed  CAS  Google Scholar 

  38. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnea with myocardial infarction in men. Lancet. 1990;336:261.

    Article  PubMed  CAS  Google Scholar 

  39. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26–30.

    Google Scholar 

  40. Saletu M, Sauter C, Lalouschek W, Saletu B, Kapfhammer G, Benesch T, et al. Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea? Atherosclerosis. 2008;196:810–6.

    Article  PubMed  CAS  Google Scholar 

  41. Scharf SM, Bianco JA, Tow DE, Brown R. The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary a2tery disease. Circulation. 1981;63:871–5.

    Article  PubMed  CAS  Google Scholar 

  42. Can M, Açikgöz S, Mungan G, Bayraktaroğlu T, Koçak E, Güven B, Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006;129:23–7.

    Google Scholar 

  43. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176:1274.

    Article  PubMed  Google Scholar 

  44. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnea and nocturnal angina. Lancet. 1995;345:1085–7.

    Article  PubMed  CAS  Google Scholar 

  45. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke. 2001;32:1271–8.

    Article  PubMed  CAS  Google Scholar 

  46. Arzt M, Yount T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.

    Article  PubMed  Google Scholar 

  47. McArdle N, Riha RL, Vennelle M, Coleman EL, Dennis MS, Warlow CP, Douglas NJ. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case–control study in patients with transient ischemic attacks. Stroke. 2003;34:2916–21.

    Google Scholar 

  48. Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ. Sleep-disordered breathing after stroke: a randomized controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatr. 2006;77:1143–9.

    Google Scholar 

  49. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep. 2008;31:1207–13.

    PubMed  Google Scholar 

  50. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008;168:297–301.

    Google Scholar 

  51. Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea. a 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36–41.

    Google Scholar 

  52. Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24:267–72.

    Google Scholar 

  53. Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, Soler-Cataluña JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest. 2005;128:2123–9.

    Google Scholar 

  54. • Martínez-García MA, Campos-Rodríguez F, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Montserrat JM. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnea: effect of CPAP treatment. Eur Respir J. 2012;39:906–12. Well-conducted multicenter trial from Spain assessing CPAP treatment in stroke patients.

    Article  PubMed  Google Scholar 

  55. Wessendorf TE, Wang YM, Thilmann AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure in stroke. Eur Respir J. 2001;18:623–9.

    Article  PubMed  CAS  Google Scholar 

  56. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006;13:198–200.

    Article  PubMed  CAS  Google Scholar 

  57. Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnea: a randomized treatment study. Eur Respir J. 2001;18:630–4.

    Article  PubMed  CAS  Google Scholar 

  58. Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med. 2009;103:59–66.

    Article  PubMed  Google Scholar 

  59. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–9.

    Article  PubMed  CAS  Google Scholar 

  60. Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716–22.

    Article  PubMed  Google Scholar 

  61. Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness; a randomized, controlled trial. Ann Intern Med. 2001;134:1015–23.

    Article  PubMed  CAS  Google Scholar 

  62. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229–35.

    Article  PubMed  CAS  Google Scholar 

  63. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.

    Google Scholar 

  64. Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005;294:3124–30.

    Article  PubMed  CAS  Google Scholar 

  65. Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary edema: a meta-analysis. Lancet. 2006;367:1155–63.

    Article  PubMed  Google Scholar 

  66. Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev. 2008;3, CD005351.

    PubMed  Google Scholar 

  67. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473–9.

    Article  PubMed  CAS  Google Scholar 

  68. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025–33.

    Article  PubMed  CAS  Google Scholar 

  69. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61–6.

    Article  PubMed  CAS  Google Scholar 

  70. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115:3173–80.

    Article  PubMed  Google Scholar 

  71. Arzt M, Schulz M, Schroll S, Budweiser S, Bradley TD, Riegger GA, et al. Time course of continuous positive airway pressure effects on central sleep apnea in patients with chronic heart failure. J Sleep Res. 2009;18:20–5.

    Article  PubMed  Google Scholar 

  72. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998;98:2269–75.

    Article  PubMed  CAS  Google Scholar 

  73. Khayat RN, Abraham WT, Patt B, Roy M, Hua K, Jarjoura D. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study. Chest. 2008;134:1162.

    Article  PubMed  Google Scholar 

  74. Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servo-ventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest. 2012.

  75. Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al. JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail. 2010;3:140–8.

    Article  PubMed  Google Scholar 

  76. Otsuka K, Sadakane N, Ozawa T. Arrythmogenic properties of disordered breathing during sleep in patients with cardiovascular disorders. Clin Cardiol. 1987;10:771–82.

    Article  PubMed  CAS  Google Scholar 

  77. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Sleep Heart Health Study Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med. 2006;173:910–6.

    Article  PubMed  Google Scholar 

  78. Simantirakis EN, Schiza SI, Marketou ME, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25:1070–6.

    Google Scholar 

  79. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.

    Google Scholar 

  80. Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherison C, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med. 2002;346:4404–12.

    Article  Google Scholar 

  81. Luthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B, et al. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnea. Eur J Heart Fail. 2009;11:273–80.

    Article  PubMed  Google Scholar 

  82. Pepin JL, Defaye P, Garrigue S, Poezevara Y, Levy P. Overdrive pacing does not improve obstructive sleep apnea syndrome does not improve obstructive sleep apnea syndrome. Eur Respir J. 2005;25:343–7.

    Article  PubMed  Google Scholar 

  83. Simantirakis EN, Schiza SE, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, Siafakas NM, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med. 2005;353:2568–77.

    Article  PubMed  CAS  Google Scholar 

  84. Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007;8:31–6.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Athanasia Pataka declares that she has no conflict of interest.

Renata L. Riha declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renata L. Riha.

Additional information

This article is part of the Topical Collection on Ischemic Heart Disease

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pataka, A., Riha, R.L. Continuous Positive Airway Pressure and Cardiovascular Events in Patients with Obstructive Sleep Apnea. Curr Cardiol Rep 15, 385 (2013). https://doi.org/10.1007/s11886-013-0385-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-013-0385-z

Keywords

Navigation